1. Home
  2. SERA vs SRG Comparison

SERA vs SRG Comparison

Compare SERA & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • SRG
  • Stock Information
  • Founded
  • SERA 2008
  • SRG 2014
  • Country
  • SERA United States
  • SRG United States
  • Employees
  • SERA N/A
  • SRG N/A
  • Industry
  • SERA Precision Instruments
  • SRG Real Estate Investment Trusts
  • Sector
  • SERA Health Care
  • SRG Real Estate
  • Exchange
  • SERA Nasdaq
  • SRG Nasdaq
  • Market Cap
  • SERA 258.3M
  • SRG 254.9M
  • IPO Year
  • SERA 2021
  • SRG 2015
  • Fundamental
  • Price
  • SERA $6.92
  • SRG $4.56
  • Analyst Decision
  • SERA
  • SRG
  • Analyst Count
  • SERA 0
  • SRG 0
  • Target Price
  • SERA N/A
  • SRG N/A
  • AVG Volume (30 Days)
  • SERA 140.4K
  • SRG 249.9K
  • Earning Date
  • SERA 11-06-2024
  • SRG 11-06-2024
  • Dividend Yield
  • SERA N/A
  • SRG N/A
  • EPS Growth
  • SERA N/A
  • SRG N/A
  • EPS
  • SERA N/A
  • SRG N/A
  • Revenue
  • SERA $107,000.00
  • SRG $59,030,000.00
  • Revenue This Year
  • SERA N/A
  • SRG N/A
  • Revenue Next Year
  • SERA $2,020.00
  • SRG N/A
  • P/E Ratio
  • SERA N/A
  • SRG N/A
  • Revenue Growth
  • SERA N/A
  • SRG 274.65
  • 52 Week Low
  • SERA $1.56
  • SRG $3.63
  • 52 Week High
  • SERA $12.36
  • SRG $9.87
  • Technical
  • Relative Strength Index (RSI)
  • SERA 42.37
  • SRG 49.87
  • Support Level
  • SERA $6.87
  • SRG $4.45
  • Resistance Level
  • SERA $8.19
  • SRG $4.66
  • Average True Range (ATR)
  • SERA 0.50
  • SRG 0.13
  • MACD
  • SERA -0.08
  • SRG 0.01
  • Stochastic Oscillator
  • SERA 3.68
  • SRG 51.16

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management and leasing of diversified and mixed-use properties throughout the United States.

Share on Social Networks: